Search

Kevyn E Merten

from Louisville, KY
Age ~47
Get Report
Related to:
Katherine M Merten, 46Robert Dale MertenKrysten E Merten, 39Erik Merten, 50Cheryl Merten, 77James Merten, 79Thomas Mckechnie, 71
Connected to:
Audrey V Merten, 60Barbara L Merten, 81Billy M Merten, 43Catherine I Merten, 61Deborah L Merten, 73Edward H Merten, 72Guy J Merten, 59Jessica E Merten, 39Keri Merten, 35Kyle J Merten, 40

Kevyn Merten Phones & Addresses

  • 7611 Beech Spring Ct, Louisville, KY 40241 (502) 386-7036
  • 2802 Windsor Forest Dr, Louisville, KY 40272 (502) 935-6700
  • 3840 Sugar Creek Dr, Lexington, KY 40517

Work

Company: University of louisville Jul 2017 Position: Associate vice president for research and innovation

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Louisville 2005 to 2007 Specialities: Toxicology, Pharmacology

Skills

Biotechnology • Life Sciences • Molecular Biology • R&D • Fundraising

Industries

Higher Education

Resumes

Resumes

Kevyn Merten Photo 1

Associate Vice President For Research And Innovation

View page
Location:
Louisville, KY
Industry:
Higher Education
Work:
University of Louisville
Associate Vice President For Research and Innovation
University of Louisville Apr 1, 2012 - Jul 2017
Chief of Staff For the Executive Vice President For Research and Innovation
University of Louisville Apr 1, 2012 - Jul 2017
Adjunct Assistant Professor, Pharmacology and Toxicology
Pradama 2010 - Apr 2012
Vice President of Drug Development
Pradama 2007 - 2010
Associate Director of Research Operations
Education:
University of Louisville 2005 - 2007
Doctorates, Doctor of Philosophy, Toxicology, Pharmacology University of Louisville 2002 - 2005
Master of Science, Masters, Toxicology, Pharmacology University of Kentucky 1997 - 2001
Bachelors, Bachelor of Science, Biotechnology Dupont Manual H.s 1994 - 1996
Dupont Manual High School 1992 - 1996
Skills:
Biotechnology
Life Sciences
Molecular Biology
R&D
Fundraising

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kevyn Merten
Associate Director
Metacyte Business Lab Ewa
Business Services
210 E Jefferson St, Louisville, KY 40202

Publications

Us Patents

Methods And Compounds For The Targeted Delivery Of Agents To Bone For Interaction Therewith

View page
US Patent:
20130029901, Jan 31, 2013
Filed:
Jul 30, 2012
Appl. No.:
13/561555
Inventors:
K. Grant TAYLOR - Louisville KY, US
Leonard C. WAITE - Corydon IN, US
Kevyn MERTEN - Louisville KY, US
International Classification:
A61K 31/167
A61K 38/14
C07D 417/14
A61K 31/506
C07H 15/252
A61K 31/704
C07C 237/44
C07D 311/36
A61K 31/352
C07J 41/00
A61K 31/565
A61P 19/08
A61P 31/00
A61P 35/00
A61P 19/10
A61K 31/568
C07K 9/00
US Classification:
514 23, 530395, 514 167, 544295, 51425219, 536 64, 514 34, 564153, 514616, 549403, 514456, 552625, 514182, 514178, 552638
Abstract:
Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (R), having an affinity for bone; a Bone Active Portion (R) for interacting with and affecting bone; and a Linking Portion (R) connecting the Bone Targeting Portion and the Bone Active Portion.

Methods And Compounds For The Targeted Delivery Of Agents To Bone For Interaction Therewith

View page
US Patent:
20120083440, Apr 5, 2012
Filed:
Oct 5, 2011
Appl. No.:
13/253536
Inventors:
K. Grant Taylor - Louisville KY, US
Leonard C. Waite - Corydon IN, US
Kevyn Merten - Louisville KY, US
International Classification:
A61K 31/167
C07J 41/00
A61K 31/567
C07D 311/34
A61K 31/353
A61K 31/569
C07D 285/125
A61K 31/433
C07H 15/252
A61K 31/704
C07D 417/14
A61K 31/506
C07K 9/00
A61K 38/14
A61P 19/00
A61P 19/10
A61P 35/00
A61P 31/00
C07C 237/40
US Classification:
514 23, 564157, 514616, 552626, 514182, 549403, 514456, 564153, 552638, 514178, 548139, 514363, 536 64, 514 34, 544295, 51425219, 530322
Abstract:
Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (R), having an affinity for bone; a Bone Active Portion (R) for interacting with and affecting bone; and a Linking Portion (R) connecting the Bone Targeting Portion and the Bone Active Portion.

Novel Oxysterol Analogue, Oxy149, Induces Osteogenesis And Hedgehog Signaling And Inhibits Adipogenesis

View page
US Patent:
20150140059, May 21, 2015
Filed:
Mar 15, 2013
Appl. No.:
14/399105
Inventors:
- Oakland CA, US
- Louisville KY, US
Frank Stappenbeck - San Diego CA, US
William Pierce - Louisville KY, US
K. Grant Taylor - Louisville KY, US
Kevyn E. Merten - Louisville KY, US
International Classification:
C07J 41/00
A61K 45/06
C12N 5/077
A61L 31/16
A61L 31/08
A61K 31/575
A61K 35/28
US Classification:
424423, 552542, 514182, 514171, 424 937, 514 118, 424676, 514 85, 514 89, 514 88, 514 86
Abstract:
This invention relates, e.g., to a synthetic compound, Oxy149, having the structure (Formula I) or a bioactive or pharmaceutical composition comprising Oxy149 and a pharmaceutically acceptable carrier. Methods are also disclosed for using the compound or bioactive or pharmaceutical composition to treat a variety of disorders, including e.g. bone disorders, obesity, cardiovascular disorders, and neurological disorders. Oxy149 can be delivered either locally or systemically.
Control profile
Kevyn E Merten from Louisville, KY, age ~47 Get Report